Human Hepassocin/FGL1 Antibody, R&D Systems™

Mouse Monoclonal Antibody

Catalog Number	Mfr. No.	Quantity
MAB112302SP	R&D Systems MAB112302SP	25 μg
MAB11230210	R&D Systems MAB112302100	100 μg

Description

Hepassocin/FGL1 Monoclonal antibody specifically detects Hepassocin/FGL1 in Human samples. It is validated for nan

Specifications

• Antigen: Hepassocin/FGL1
• Classification: Monoclonal
• Form: Purified
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 2267
• Isotype: IgG1
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

• Clone: 1052936
• Conjugate: Unconjugated
• Host Species: Mouse
• Target Species: Human
• Gene Alias: fibrinogen-like 1, fibrinogen-like protein 1, hepassocin, hepatocellular carcinoma-related sequence, Hepatocyte-derived fibrinogen-related protein 1, HFREP-1, HFREP1MGC12455, HP-041, LFIRE1, LFIRE-1, Liver fibrinogen-related protein 1
• Immunogen: Mouse myeloma cell line NS0-derived recombinant human Hepassocin/FGL1, Met1-Ile312, Accession # BAB70690
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.